Pharma Journalist -

AstraZeneca’s Symbicort Turbuhaler (budesonide/formoterol 160/4.5mcg) has been approved in China as an anti-inflammatory reliever to be taken as-needed in response to symptoms to…
Read More...

SMi Reports: Hear key Sessions from Amgen, BSI, FDA, Biogen, Takeda, Janssen, Merck, Alexion Pharmaceuticals, Regeneron Pharmaceuticals and many more! The two-day conference agenda…
Read More...

The fully launched MAH and priority review pathways from the NMPA (National Medical Products Administration) is stimulating new demand in China for 2021. The recently hosted CPhI…
Read More...

Mundipharma and Cidara Therapeutics  announced that the European Commission (EC) has now adopted the European Medicines Agency’s (EMA) Committee for Orphan Medicinal Products (COMP)…
Read More...

Merck, known as MSD outside the United States and Canada, announced that the company is discontinuing development of its SARS-CoV-2/COVID-19 vaccine candidates, V590 and V591, and plans…
Read More...

Humanetics Corporation (Humanetics) announced that it has received funding from the U.S. Department of Defense to conduct a series of studies with its new drug candidate, BIO 300. BIO…
Read More...

Evozyne, LLC, a privately held molecular engineering technology company founded by life science innovator Paragon Biosciences, announced the signing of a strategic collaboration and…
Read More...

Moderna Inc. announced results from in vitro neutralization studies of sera from individuals vaccinated with Moderna COVID-19 Vaccine showing activity against emerging strains of…
Read More...

BioNTech SE and Shanghai Fosun Pharmaceutical (Group) Co., Ltd. announced that according to the Food and Health Bureau of the Hong Kong Special Administrative Region of the PRC ("Hong…
Read More...

SMi Reports: The only B2B parallel trade conference in Europe This conference will bring together industry experts to discuss the challenges and drivers of the industry, including…
Read More...